PMGC (NASDAQ:ELAB) Posts Quarterly Earnings Results

PMGC (NASDAQ:ELAB) issued its quarterly earnings results on Friday. The company reported ($4.01) earnings per share (EPS) for the quarter, FiscalAI reports. PMGC had a negative net margin of 522.92% and a negative return on equity of 118.83%. The business had revenue of $2.53 million during the quarter.

PMGC Stock Down 0.6%

Shares of NASDAQ:ELAB traded down $0.01 during trading on Friday, reaching $1.58. 33,472 shares of the stock were exchanged, compared to its average volume of 374,767. PMGC has a 1-year low of $1.41 and a 1-year high of $1,344.00. The stock has a fifty day moving average of $3.33 and a two-hundred day moving average of $28.16. The company has a debt-to-equity ratio of 0.02, a current ratio of 1.36 and a quick ratio of 1.30. The firm has a market cap of $1.28 million, a price-to-earnings ratio of -0.00 and a beta of -0.27.

Institutional Trading of PMGC

An institutional investor recently bought a new stake in PMGC stock. Citadel Advisors LLC acquired a new position in shares of PMGC Holdings Inc. (NASDAQ:ELAB) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 20,702 shares of the company’s stock, valued at approximately $25,000. Citadel Advisors LLC owned about 2.56% of PMGC at the end of the most recent quarter. 22.22% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of PMGC in a research note on Tuesday, September 22nd. One research analyst has rated the stock with a Sell rating. According to data from MarketBeat.com, PMGC presently has an average rating of “Sell”.

PMGC Company Profile

Elevai Labs, Inc., a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc. and changed its name to Elevai Labs, Inc. in December 2021. Elevai Labs, Inc. was incorporated in 2020 and is based in Newport Beach, California.